Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
US6121319A · kind A · utility
47Cited by
26References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 14, 1998 |
| Grant date | Sep 19, 2000 |
| Priority date | — |
| Expiry date | May 14, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C323/67
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is a method and composition for the inhibition of VCAM-1, and in particular for the treatment of cardiovascular or inflammatory disease, including atherosclerosis, that includes the administration of an effective amount of an ester of probucol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.